170 related articles for article (PubMed ID: 30358832)
1. Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.
Kalkman DN; Aquino M; Claessen BE; Baber U; Guedeney P; Sorrentino S; Vogel B; de Winter RJ; Sweeny J; Kovacic JC; Shah S; Vijay P; Barman N; Kini A; Sharma S; Dangas GD; Mehran R
Eur Heart J; 2018 Dec; 39(46):4101-4108. PubMed ID: 30358832
[TBL] [Abstract][Full Text] [Related]
2. Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention.
Guedeney P; Claessen BE; Kalkman DN; Aquino M; Sorrentino S; Giustino G; Farhan S; Vogel B; Sartori S; Montalescot G; Sweeny J; Kovacic JC; Krishnan P; Barman N; Dangas G; Kini A; Baber U; Sharma S; Mehran R
J Am Coll Cardiol; 2019 May; 73(19):2401-2409. PubMed ID: 31097159
[TBL] [Abstract][Full Text] [Related]
3. The residual risk of inflammation and remnant cholesterol in acute coronary syndrome patients on statin treatment undergoing percutaneous coronary intervention.
Liao J; Qiu M; Su X; Qi Z; Xu Y; Liu H; Xu K; Wang X; Li J; Li Y; Han Y
Lipids Health Dis; 2024 Jun; 23(1):172. PubMed ID: 38849939
[TBL] [Abstract][Full Text] [Related]
4. Residual Inflammatory Risk and its Association With Events in East Asian Patients After Coronary Intervention.
Ahn JH; Tantry US; Kang MG; Park HW; Koh JS; Bae JS; Cho SY; Kim KH; Jang JY; Park JR; Park Y; Hwang SJ; Kwak CH; Hwang JY; Gurbel PA; Jeong YH
JACC Asia; 2022 Jun; 2(3):323-337. PubMed ID: 36338415
[TBL] [Abstract][Full Text] [Related]
5. Combined impact of residual inflammatory risk and chronic kidney disease on long-term clinical outcomes in patients undergoing percutaneous coronary intervention.
Nishio R; Dohi T; Takeuchi M; Takahashi N; Endo H; Doi S; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
J Cardiol; 2022 Apr; 79(4):509-514. PubMed ID: 34799214
[TBL] [Abstract][Full Text] [Related]
6. Relationship of Serial High-Sensitivity C-Reactive Protein Changes to Long-term Clinical Outcomes in Stabilised Patients After Myocardial Infarction.
Lee M; Lee K; Kim DW; Cho JS; Kim TS; Kwon J; Kim CJ; Park CS; Kim HY; Yoo KD; Jeon DS; Chang K; Kim MC; Jeong MH; Ahn Y; Park MW
Can J Cardiol; 2022 Jan; 38(1):92-101. PubMed ID: 34737035
[TBL] [Abstract][Full Text] [Related]
7. Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention.
Takahashi N; Dohi T; Endo H; Funamizu T; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32268533
[TBL] [Abstract][Full Text] [Related]
8. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial.
Prasad A; Gössl M; Hoyt J; Lennon RJ; Polk L; Simari R; Holmes DR; Rihal CS; Lerman A
Catheter Cardiovasc Interv; 2013 May; 81(6):930-6. PubMed ID: 22517646
[TBL] [Abstract][Full Text] [Related]
9. Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention.
Ogita M; Miyauchi K; Tsuboi S; Shitara J; Endo H; Wada H; Doi S; Naito R; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Suwa S; Daida H
Am J Cardiol; 2015 Oct; 116(7):999-1002. PubMed ID: 26243577
[TBL] [Abstract][Full Text] [Related]
10. Association of residual inflammatory risk with stroke recurrence in patients with acute ischaemic stroke or transient ischaemic attack.
Liu H; Wang M; Xiang X; Pan Y; Li J; Meng X; Li H; Li Z; Jing J; Wang Y
Eur J Neurol; 2022 Aug; 29(8):2258-2268. PubMed ID: 35380744
[TBL] [Abstract][Full Text] [Related]
11. Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention.
Gu G; Yuan X; Zhou Y; Liu D; Cui W
BMC Cardiovasc Disord; 2019 Jun; 19(1):152. PubMed ID: 31234798
[TBL] [Abstract][Full Text] [Related]
12. Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events.
Klingenberg R; Aghlmandi S; Gencer B; Nanchen D; Räber L; Carballo D; Carballo S; Stähli BE; Landmesser U; Rodondi N; Mach F; Windecker S; Bucher HC; von Eckardstein A; Lüscher TF; Matter CM
Atherosclerosis; 2021 Mar; 320():31-37. PubMed ID: 33524907
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry.
Valle JA; McCoy LA; Maddox TM; Rumsfeld JS; Ho PM; Casserly IP; Nallamothu BK; Roe MT; Tsai TT; Messenger JC
Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404621
[TBL] [Abstract][Full Text] [Related]
14. Combined and independent impact of coronary artery calcification and inflammation on risk for adverse cardiovascular events after percutaneous coronary intervention: Results from a large single-center registry.
Aoi S; Baber U; Kovacic JC; Mehran R; Aquino M; Dangas G; Sweeny J; Vijay P; Shah S; Barman N; Moreno P; Kini AS; Sharma SK
Catheter Cardiovasc Interv; 2020 Sep; 96(3):E278-E286. PubMed ID: 32087000
[TBL] [Abstract][Full Text] [Related]
15. Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study).
Redfors B; Chen S; Ben-Yehuda O; Huang X; Witzenbichler B; Weisz G; Liu Y; Brodie BR; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Mehran R; Stuckey TD; Kirtane AJ; Stone GW
Am J Cardiol; 2019 Nov; 124(9):1380-1388. PubMed ID: 31477234
[TBL] [Abstract][Full Text] [Related]
16. Routine angiographic follow-up versus clinical follow-up in patients with multivessel coronary artery diseases following percutaneous coronary intervention with drug-eluting stents: a nested case-control study within a Korean population.
Kim YH; Her AY; Rha SW; Choi BG; Shim M; Choi SY; Byun JK; Li H; Kim W; Kang JH; Choi JY; Park EJ; Park SH; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
Coron Artery Dis; 2017 Jun; 28(4):307-314. PubMed ID: 28272162
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of Discharge Resting Heart Rate to Predict Adverse Cardiovascular Outcomes in Patients With Left Main Coronary Artery Disease Revascularized With Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting (from the EXCEL Trial).
Kosmidou I; Crowley A; Macedo L; Ben-Yehuda O; Gersh BJ; Boonstra PW; Kappetein AP; Serruys PW; Sabik JF; Stone GW
Am J Cardiol; 2020 Jan; 125(2):169-175. PubMed ID: 31735328
[TBL] [Abstract][Full Text] [Related]
18. Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes.
Yang X; Tamez H; Lai C; Ho K; Cutlip D
Catheter Cardiovasc Interv; 2017 Apr; 89(5):849-856. PubMed ID: 27535209
[TBL] [Abstract][Full Text] [Related]
19. Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: COLCHICINE-PCI Randomized Trial.
Shah B; Pillinger M; Zhong H; Cronstein B; Xia Y; Lorin JD; Smilowitz NR; Feit F; Ratnapala N; Keller NM; Katz SD
Circ Cardiovasc Interv; 2020 Apr; 13(4):e008717. PubMed ID: 32295417
[TBL] [Abstract][Full Text] [Related]
20. Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention.
Mehta V; Sukhija R; Mehra P; Goyal A; Yusuf J; Mahajan B; Gupta VK; Tyagi S; Palaniswamy C; Aronow WS
Indian Heart J; 2016; 68(1):57-62. PubMed ID: 26896268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
